Continuing Treatment for Children and Adults in the Center for Cancer Research
It may be in the interest of the CCR to continue to follow and treat certain subjects after
they have completed their treatment and participation on a research protocol.
To provide continuing treatment and medical follow-up for CCR subjects who have completed
their treatment and participation on a research protocol and who are not currently entered
on or eligible for another active research protocol.
Subjects who have been previously enrolled on and received treatment according to an
approved CCR research protocol. (clinical trial)
It is in the best interest of the subject and the CCR for the subject to continue to receive
standard care and follow-up at the NIH.
Medical/surgical/radiotherapeutic care, treatment and follow-up is provided for CCR subjects
who have completed their treatment and participation on a research protocol and who are not
currently entered on an active research protocol.
No investigational treatments will be administered. This protocol is not be used as a
platform to perform pilot studies of off-label uses for standard agents.
Caryn Steakley, R.N.
National Cancer Institute (NCI)
United States: Federal Government
|National Institutes of Health Clinical Center, 9000 Rockville Pike||Bethesda, Maryland 20892|